Julie Marie Postma1, Tamara Odom-Maryon2, Ana G Rappold3, Hans Haverkamp4, Solmaz Amiri5, Ross Bindler6, Justin Whicker7, Von Walden8. 1. Professor, Associate Dean for Research, Washington State University College of Nursing, Spokane, Washington, USA. 2. Research Professor, Washington State University College of Nursing, Spokane, Washington, USA. 3. Center for Public Health and Environmental Assessment, Branch Chief, Clinical Research Branch, Office of Research and Development, United States Environmental Protection Agency (U.S. EPA), Durham, North Carolina, USA. 4. Associate Professor, Washington State University Elson S. Floyd College of Medicine, Spokane, Washington, USA. 5. Assistant Research Professor, Washington State University Elson S. Floyd College of Medicine, Department of Medical Education and Clinical Sciences, Institute for Research and Education to Advance Community Health, Washington State University, Seattle, Washington, USA. 6. Research Coordinator, Washington State University College of Nursing, Spokane, Washington, USA. 7. Software engineer, Urbanova, Spokane, Washington, USA. 8. Professor, Washington State University Voiland College of Engineering and Architecture, Pullman, Washington, USA.
Abstract
OBJECTIVE(S): This study explored the feasibility, acceptability, preliminary impact, and functionality of two risk reduction mobile application (app) interventions on asthma outcomes as compared to a control arm during wildfire season. DESIGN: Three-arm, 8-week randomized clinical trial. SAMPLE: Sixty-seven young adults with asthma were enrolled. MEASUREMENTS: The Asthma Control Test, forced expiratory volume in one second (FEV1 ) and the System Usability Scale were measured at baseline, 4, and 8 weeks. The Research Attitude Scale was administered at 8 weeks. Twenty participants from the two intervention arms completed an optional survey and six were interviewed after completing the study. INTERVENTION: Both intervention arms could access Smoke Sense Urbanova, an app that supports reducing risks from breathing wildfire smoke. The Smoke Sense Urbanova Plus arm also monitored their daily FEV1 , received air quality notifications, and accessed preventive tips and a message board. RESULTS: Most participants agreed the app and spirometer were usable and their privacy and confidentiality were maintained. No adverse events were reported. CONCLUSIONS: Participant-identified recommendations will support intervention refinement and testing. This research supports asthma self-management tools that public health nurses and community health workers can recommend for at-risk populations.
OBJECTIVE(S): This study explored the feasibility, acceptability, preliminary impact, and functionality of two risk reduction mobile application (app) interventions on asthma outcomes as compared to a control arm during wildfire season. DESIGN: Three-arm, 8-week randomized clinical trial. SAMPLE: Sixty-seven young adults with asthma were enrolled. MEASUREMENTS: The Asthma Control Test, forced expiratory volume in one second (FEV1 ) and the System Usability Scale were measured at baseline, 4, and 8 weeks. The Research Attitude Scale was administered at 8 weeks. Twenty participants from the two intervention arms completed an optional survey and six were interviewed after completing the study. INTERVENTION: Both intervention arms could access Smoke Sense Urbanova, an app that supports reducing risks from breathing wildfire smoke. The Smoke Sense Urbanova Plus arm also monitored their daily FEV1 , received air quality notifications, and accessed preventive tips and a message board. RESULTS: Most participants agreed the app and spirometer were usable and their privacy and confidentiality were maintained. No adverse events were reported. CONCLUSIONS: Participant-identified recommendations will support intervention refinement and testing. This research supports asthma self-management tools that public health nurses and community health workers can recommend for at-risk populations.
Authors: Robert A Nathan; Christine A Sorkness; Mark Kosinski; Michael Schatz; James T Li; Philip Marcus; John J Murray; Trudy B Pendergraft Journal: J Allergy Clin Immunol Date: 2004-01 Impact factor: 10.793
Authors: Colleen E Reid; Michael Brauer; Fay H Johnston; Michael Jerrett; John R Balmes; Catherine T Elliott Journal: Environ Health Perspect Date: 2016-04-15 Impact factor: 9.031
Authors: Brian L Graham; Irene Steenbruggen; Martin R Miller; Igor Z Barjaktarevic; Brendan G Cooper; Graham L Hall; Teal S Hallstrand; David A Kaminsky; Kevin McCarthy; Meredith C McCormack; Cristine E Oropez; Margaret Rosenfeld; Sanja Stanojevic; Maureen P Swanney; Bruce R Thompson Journal: Am J Respir Crit Care Med Date: 2019-10-15 Impact factor: 21.405
Authors: A G Rappold; M C Hano; S Prince; L Wei; S M Huang; C Baghdikian; B Stearns; X Gao; S Hoshiko; W E Cascio; D Diaz-Sanchez; B Hubbell Journal: Geohealth Date: 2019-12-10